No Detail Found!

Seroprevalence, Biochemical Investigation and Risk Factor Assessment for HBV & HCV Infection in Hospital Based Patients of Islamabad, Pakistan

Author(s)
Narmeen Adnan Rana Department of Biosciences, COMSATS University Islamabad, Pakistan.
Bushra Munir Department of Biosciences, COMSATS University Islamabad, Pakistan.
Nazeer Hussain Capital Development Authority (CDA) Hospital, Islamabad, Pakistan.
Nazia Imtiaz Capital Development Authority (CDA) Hospital, Islamabad, Pakistan.
Muhammad Asif Gondal Department of Biosciences, COMSATS University Islamabad, Pakistan.
Fahed Parvaiz Department of Biosciences, COMSATS University Islamabad, Pakistan.
Abstract
Viral hepatitis poses a serious threat to mankind. Hepatitis B and C Virus are blood borne pathogens that affect millions of individually globally. This study was conducted on a hospital-based population in Islamabad, Pakistan over a period of 4 months, utilizing ELISA as the diagnostic technique which suggested a higher seroprevalence rate for both HBV and HCV i.e. 2.07% and 8.24% respectively. A correlational analysis of the biochemical parameters of these individuals with HBV and HCV infection was carried out and the results indicated a positive correlation of HBV with Alkaline Phosphatase (ALP), HCV with Total Bilirubin (TBil) and both the viruses with Alanine Aminotransferase (ALT). Furthermore, the risk factors in relation to these viral infections were explored upon which our data suggested that surgery, blood transfusion and contact with contaminated instruments at the barber for haircut/shaving and jewelers for piercings were the major risk factors responsible for aiding the contraction of the viral disease by patients in the hospital. These high percentages of the viral infection among the population require proper management and prevention techniques to minimize the number of casualties and further cases to provide a healthier surrounding for the people to live in.
Publication Details
Page(s) 10-18
Published Journal: Journal of Bioresource Management, Volume: 7, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
HBV, Seroprevalence, HCV, Risk factor., biochemical investigation
References
Abulude OA,Ahmed IL,Sadisu FU .2017 .Assessment of Hepatitis B Viral Infection as a Predictor of Hepatic Enzymes and Compounds Alteration among Antenatal Patients. , 5(4) : 24.
Aguiar J,Rodriguez L,León Y,Freyre F,Silva JA,Montalvo MC,Guillén G .2014 .Hepatitis B virus DNA quantification using a cost effective and simple real time PCR in Cuban carriers. J Infect Dis Ther., 2(1) : 49-58.
Ali SA,Donahue RMJ,Qureshi H,Vermund SH .2008 .Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis., 06(1) : 9-19.
Ali A,Ahmad H,Ali I,Khan S,Zaidi G,Idrees M .2010 .Prevalence of active hepatitis c virus infection in district Mansehra Pakistan. , 7(1) : 334.
Anwar MI,Rahman M,Hassan MU,Iqbal M .2013 .Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. , 10(1) : 351.
Arshad A,Ashfaq UA .2017 .Epidemiology of hepatitis C infection in Pakistan: current estimate and major risk factors. Crit Rev Eukar Gene., 27(1) : .
Asia B,Bano KA,Misbah- KA,-Islam K,Riaz H K .2008 .Antenatal screening of women for hepatitis B and C in an out-patient department. J Dow Univ Health Sci., 2(1) : 32-35.
Bukhari SM,Khatoon N,Iqbal A,Naeem S,Shafqat S,Lone A,Naveed IA .1999 .Prevalence of hepatitis B antigenaemia in Mayo Hospital Lahore. , 15 : 88-91.
Catanese MT,Uryu K,Kopp M,Edwards TJ,Andrus L,Rice WJ,Rice CM .2013 .Ultrastructural analysis of hepatitis C virus particles. Proc Natl Acad Sci., 110(23) : 9505-9510.
Chen J,Zhang W Lin,Wang F,Wu M Chen C and Yuan Z F .2014 .An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases. Mol Ther, 22(2) : 303-311.
Chen SL,Morgan TR .2006 .The natural history of hepatitis C virus (HCV) infection. Int J Med Sci., 3(2) : 47.
Datta S,Chatterjee S,Veer V,Chakravarty R V .2012 .Molecular biology of the hepatitis B virus for clinicians. J Clin Exp Hepatol, 2(4) : 353-365.
El-Kady AM,Abo-El-Kheir HEF,ElHadidy AS HEF .2017 .Study of some serum biochemical markers of liver fibrosis in patients with chronic HCV. J Clin Gastroenterol Hepatol, 1 : 2-10.
Fauteux-Daniel S,Larouche A,Calderon V,Boulais J,Béland C,Ransy DG,Le Campion A .2017 .Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection. J Virol., JVI-01372., : .
Fayyaz M,Qazi MA,Ishaq M,Chaudhry GM,Bukhari MH .2006 .Frequency of hepatitis B and C seropositivity in prisoners. , 22 : 55-58.
Haider J,Lufullah G,Nazli R,Akhtar T,Shah A .2017 .Screening of adult dental patients visiting Khyber College of Dentistry, Peshawar for HBV and HCV infections and identifying the associated risk factors. Pak J Med Sci., 33(3) : 615.
Idrees MK,Batool S,Ahmed E .2011 .Hepatitis B virus among maintainence haemodialysis patients: a report from Karachi, Pakistan. Age (years). J Pak Med, 61(12) : 1210-1214.
Ijaz B,Ahmad W,Javed FT,Gull S,Sarwar MT,Kausar H,Asad S,Jahan S,Khaliq S,Shahid I,Sumrin A .2011 .Association of laboratory parameters with viral factors in patients with hepatitis C. Virol J. , 8(1) : 361.
Iqbal S,Sheikh MA,Arshad M .2014 .Response of different HCV genotypes to interferon therapy in different age groups of chronic hepatitis-C patients. J Ayub Med, 26(3) : 310-315.
Janjua NZ,Akhtar S,Hutin YJ,Int J Qual Health C. .2005 .Injection use in two districts of Pakistan: implications for disease prevention. , 17(5) : 401-408.
Karim SMF,Rahman MR,Shermin S,Sultana R .2015 .Correlation between aminotransferase ratio (AST/ALT) and other biochemical parameters in chronic liver disease of viral origin. Delta Med Coll J., 3(1) : 13-17.
Kazi AM,Shah SA,Jenkins CA,Shepherd BE,Vermund SH .2010 .Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis., 14 : e60-e66.
Khan F,Shams S,Qureshi ID,Israr M,Khan H,Sarwar MT,Ilyas M .2011 .Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. , 8(1) : 225.
Khan J,Khan N,ur Rahman A,Khan SN,Shah H,Din RU H .2016 .Biochemical and Molecular Characterization of Hepatitis B Virus in Dera Ismail Khan Division. J Health Sci., 6(4) : 62-66.
Kim WR,Flamm SL,Di Bisceglie AM,Bodenheimer HC .2008 .Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology., 47(4) : 1363-1370.
Kuo I,Galai N,Thomas DL,Zafar T,Ahmed MA,Strathdee SA .2006 .High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. , 3(1) : 26.
Liaw YF,Leung N,Lau GK,Merican I,McCaughan G,Omata M .2005 .Asia Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Inter, 25(3) : 472-489.
Limdi JK,Hyde G .2003 .Evaluation of abnormal liver function tests. Postgrad Med, 79(932) : 307-312.
Locasciulli A,Cavalletto D,Pontisso P,Cavalletto L,Scovena E,Uderzo C .1993 .Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood, 82(8) : 2564-2567.
Lok AS,McMahon BJ .2007 .Chronic hepatitis B. , 45 : 507-539.
Mastoi AA,Devrajani BR,Shah SZA,Rohopoto Q,Memon SA,Baloch M,Qureshi GA,Sami W .2010 .Metabolic investigations in patients with hepatitis B and C. , 16(5) : 603.
Mehnaz A,Syed S,Hasmi H S .2002 .Hepatitis B markers in mothers and its transmission in newborn. J Coll Physici., 12(4) : 240-242.
Mohamadnejad M,Pourshams A,Malekzadeh R,Mohamadkhani A,Rajabiani A,Asgari A,Mamar-Abadi M .2003 .Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroentero., 9(10) : 2322.
Muzaffar F,Hussain I,Haroon TS .2016 .Hepatitis C: the dermatologic profile. J Pakistan Assoc Dermatologists., 18(3) : 171-181.
Naz S,Ahmad M,Asghar H M .2002 .Int J Agri Biol. , 4 : 227-230.
Olut AI,Ozunlu H,Bozdag H,Ozkalay N H .2007 .The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers. , 41(3) : 429-433.
Pattullo V .2015 .Hepatitis B reactivation in the setting of chemotherapy and immunosuppression-prevention is better than cure. World J Hepatol., 7(7) : 954.
Pawlotsky JM .2002 .Use and interpretation of virological tests for hepatitis C. Hepatology. , 36 : s65-s73.
Rahman M,Khan SA,Lodhi Y .2008 .Unconfirmed reactive screening tests and their impact on donor management. Pak J Med Sci., 24(4) : 517-9.
Schweitzer A,Horn J,Mikolajczyk RT,Krause G,Ott JJ .2015 .Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. , 386(10003) : 1546-1555.
Mason WS Seeger C .2000 .Hepatitis B virus biology. Microbiol Mol Biol R., 64(1) : 51-68.
Sharif AA,Getso MI,Yusuf MA,Yusuf I,Muhd IZ,Ahmad IM .2016 .Liver function biomarkers in malaria and hepatitis B co-infection among patients with febrile illness. Int J Med R Health Sci., 5(1) : 29-32.
Sleisenger MH,Fordtran JS,Scharschmidt BF .1998 .Gastrointestinal and liver disease. Gastrointestinal disease: pathophysiology, diagnosis and treatment 6th ed. , : 1296-1360.
Thapa BR,Walia A .2007 .Liver function tests and their interpretation. Indian J. Pediatr., 74(7) : 663-671.
Torres C,Fernández MDB,Flichman DM,Campos RH,Mbayed VA .2013 .Influence of overlapping genes on the evolution of human hepatitis B virus. , 441(1) : 40-48.
Umer M,Iqbal M .2016 .Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data. World J Gastroentero., 22(4) : 1684.
Waheed Y,Siddiq M Y .2018 .Elimination of hepatitis from Pakistan by 2030: Is it possible. Hepatoma Res., 4 : 45.
Waheed Y,Shafi T,Safi SZ,Qadri I .2009 .Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroentero., 15(45) : 5647.
Wahib AA,el-Nasr MS,Mangoud AM,elShazly AM,Morsy AT .2006 .The liver profile in patients with hepatitis C virus and/or fascioliasis. J Egypt Soc Parasitol, 36(2) : 405-440.
Whitehead MW,Hawkes ND,Hainsworth I,Kingham JGC .1999 .A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. , 45(1) : 129-133.
World Health Organization .2017 .. Global hepatitis report, : .
Yousfani S,Mumtaz F,Memon A,Memon MA,Sikandar R .2006 .Antenatal screening for hepatitis B and C virus carrier state at a university hospital. J Liaquat Uni Med Health Sci., 5(1) : 24-27.
Zhu R,Zhang HP,Yu H,Li H,Ling YQ,Hu XQ,Zhu HG .2008 .Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients. Pathol Res Pract, 204(10) : 731-742.
0

Citations

0

Downloads

11

Views